Modern Pathology - The Role of Cell Cycle Regulatory Protein, Cyclin D1, in the Progression of Thyroid Cancer Skip to main content Thank you for visiting nature.com.

Melck A et al. (2007) Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol 14: 3403–3411 ...

Thyroid cancers develop when cells in the thyroid become abnormal and grow uncontrollably or do not die at the correct point in their life cycle. Read on to learn about how long it can take for ...

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up S Filetti and others Annals of Oncology, 2019. Volume 30, Issue 12, Pages 1856–1883. British Thyroid ...

A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types ...

These new studies are the latest examples of how our whole-transcriptome-based Afirma GRID research tool is helping to advance our collective understanding of thyroid cancer at the molecular level,” ...

PT162 was designed to act as a p53-reactivating cell cycle checkpoint inhibitor, inducing cancer cell cycle arrest and/or apoptosis by restoring DNA-binding activity of mutant p53 protein.

RAI is taken by mouth. Since only thyroid tissue takes up iodine in the body, RAI destroys thyroid tissue and thyroid cancer cells without harming other tissue. The amount given depends on the type ...